Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 70.05
+2.00 (2.94%)
Oct 27, 2026, 12:19 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.21 billion as of October 26, 2026. It is the 8,583rd most valuable company in the world and the 64th biggest in Spain. Its market cap has decreased by 5.03% in one year.
Market Cap
1.21B
Enterprise Value
1.09B
Revenue
218.64M
Global Rank
Country Rank
#64 Spain
PE Ratio
22.51
ChartMarket Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.21B, a decrease of -32.50%. That is a compound annual growth rate of -3.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.21B | -5.79% |
| Dec 31, 2025 | 1.29B | -7.20% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.37B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Faes Farma | 1.46B |
| Clínica Baviera | 849.76M |
| Prim, S.A. | 211.75M |
| Laboratorio Reig Jofre | 209.29M |
| Oryzon Genomics | 204.91M |